Author

K Adegoke

Observed names: K.T. Adegoke, Kehinde Adegoke

OpenAlex ID: A5112977825

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 41

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 2

Impact of COVID-19 Pandemic Lockdown on Oral Hygiene Practices and Willingness to utilize Dental Services among Patient Attendees of a Primary Oral Health Care Clinic in Ibadan, Nigeria

2021 · S.J. Akinloye, I.F. Sopeju, et al. · Nigerian Dental Journal · 1

COVID-19: Can It Qualify as a Force Majeure Event in a Commercial Agreement in Nigeria?

2020 · Kehinde Adegoke · SSRN Electronic Journal

Works count: 6

Citation count: 97

H-index: 3

I10-index: 3